Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806984 · ClinicalTrials.gov registry record
Improving Gap Closure Rates Using a Predictive Model
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 34,896
- Enrollment target
NCT04806984: Completed study, sponsored by NYU Langone Health.
NCT04806984 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 34,896 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04806984 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 34,896 participants
- Enrollment target
Study Summary
NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year.
Interventions
- OTHER Participant outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,896 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2022-02-27 |
What the finished NCT04806984 record still lists
NCT04806984 is an observational study that tracks outcomes without assigning an intervention. Its 34,896 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Participant outreach is the first listed.
NCT04806984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04806984 about?
NCT04806984 is a clinical study titled "Improving Gap Closure Rates Using a Predictive Model". NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year.
What is the current status of trial NCT04806984?
This trial is currently completed. The enrollment target is 34,896 participants. The study started on 2021-02-09. Estimated completion is 2022-02-27.
What interventions are being tested in trial NCT04806984?
The interventions under investigation include: Participant outreach (OTHER).
Who is sponsoring clinical trial NCT04806984?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI